In vitro activities of the new ketolide HMR 3647 (telithromycin) in comparison with those of eight other antibiotics against viridans group streptococci isolated from blood of neutropenic patients with cancer

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 2, 2001, Pages 624-626

  Alcaide, F ^a   Benitez M A ^a   Carratala J ^a   Gudiol, F ^a   Linares J ^a   Martin R ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; KETOLIDE; PENICILLIN G; TELITHROMYCIN; VANCOMYCIN;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATION; BLOOD SAMPLING; CANCER PATIENT; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ANTI-BACTERIAL AGENTS; HUMANS; KETOLIDES; MACROLIDES; MICROBIAL SENSITIVITY TESTS; NEOPLASMS; NEUTROPENIA; STREPTOCOCCUS;

EID: 0035139646     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.2.624-626.2001     Document Type: Article

References (30)

1. In vitro activities of 22 β-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood
2. In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients
3. Streptococcal and enterococcal bacteremia in patients with cancer
4. In vitro activities of the ketolide HMR 3647 against recent gram-positive clinical isolates and Haemophilus influenzae
5. Streptococcus viridans bacteremia following autologous peripheral blood stem cell transplantation
6. Bacteremia due to viridans streptococci in neutropenic patients: A review
7. Bacteremia due to viridans streptococcus in neutropenic patients with cancer: Clinical spectrum and risk factors
8. Nomenclature for aerobic and facultative bacteria
9. Bacteremia due to viridans streptococci that are highly resistant to penicillin: Increase among neutropenic patients with cancer
10. Streptococcus mitis sepsis in bone marrow transplant patients receiving oral antimicrobial prophylaxis
11. Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer
12. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer
13. Classification and identification of the viridans streptococci
14. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States
15. Activities of telithromycin (HMR 3647, RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and other antimicrobial agents against unusual anaerobes
16. Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution
17. Respiratory failure elicited by streptococcal septicemia in patients treated with cytosine arabinoside, and its prevention by penicillin
18. Septicemia and shock syndrome due to viridans streptococci: A case-control study of predisposing factors
19. Activity of HMR 3647 compared to those of six compounds against 235 strains of Enterococcus faecalis
20. Reduction of fever and streptococcal bacteremia in granulocytopenic patients with cancer. A trial of oral penicillin V or placebo combined with pefloxacin
21. Streptococcal bacteremia in adult patients with leukemia undergoing aggressive chemotherapy. A review of 55 cases
22. A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis
23. In vitro activities of two ketolides, HMR 3647 and HMR 3004, against gram-positive bacteria
24. In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany
25. Streptococcus
26. In vitro activity of RU 64004, a new ketolide antibiotic, against gram-positive bacteria
27. Viridans streptococcal shock in bone marrow transplantation patients
28. Antimicrobial susceptibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis